Stryker Corporation Second Quarter Earnings Sneak Peek

S&P 500 (NYSE:SPY) component Stryker Corporation (NYSE:SYK) will unveil its latest earnings on Tuesday, July 19, 2011. Stryker Corp. is a medical technology firm, which produces a range of products in medical implants, surgical technologies and emergency medical equipment. It is divided into two segments, which are Orthopaedic Implants and MedSurg Equipment.

Stryker Corporation Earnings Preview Cheat Sheet

Wall St. Earnings Expectations: The average estimate of analysts is for net income of 90 cents per share, a rise of 12.5% from the company’s actual earnings for the same quarter a year ago. The average estimate is the same as three months ago. Between one and three months ago, the average estimate was unchanged and it has not changed during the last month. For the year, analysts are projecting profit of $3.71 per share, a rise of 11.4% from last year.

Past Earnings Performance: The company’s quarterly results have come in above estimates for the last three quarters. Last quarter, the company booked net income of 90 cents per share versus a mean estimate of profit of 89 cents per share.

Savvy Investing Tip: Our CHEAT SHEET investing framework recommends only stocks with two straight quarters of earnings growth. Learn More >>

Wall St. Revenue Expectations: On average, analysts predict $2.01 billion in revenue this quarter, a rise of 14.2% from the year ago quarter. Analysts are forecasting total revenue of $8.25 billion for the year, a rise of 12.7% from last year’s revenue of $7.32 billion.

Analyst Ratings: Analysts are bullish on Stryker as 15 analysts rate it as a buy, one rates it as a sell and 14 rate it as a hold.

Key Stats:

Revenue has risen the past four quarters. Revenue increased 12% to $2.02 billion in first quarter. The figure rose 8.8% in the fourth quarter of the last fiscal year from the year earlier, climbed 6.9% in the third quarter of the last fiscal year from the year-ago quarter and 7.6% in the second quarter of the last fiscal year.

The company has now seen net income fall in each of the last two quarters. In the first quarter, net income fell 4.4% from the year earlier quarter, while the figure dropped 3.6% in the fourth quarter of the last fiscal year.

Competitors to Watch: Zimmer Holdings, Inc. (NYSE:ZMH), Exactech, Inc. (NASDAQ:EXAC), Smith & Nephew plc (NYSE:SNN), Wright Medical Group, Inc. (NASDAQ:WMGI), CONMED Corporation (NASDAQ:CNMD), ArthroCare Corporation (NASDAQ:ARTC), Medtronic, Inc. (NYSE:MDT), NuVasive, Inc. (NASDAQ:NUVA), and Alphatec Holdings, Inc. (NASDAQ:ATEC).

Stock Price Performance: During May 16, 2011 to July 13, 2011, the stock price had fallen $4.24 (-6.7%) from $63.56 to $59.32. Shares have been on a negative streak of late, closing down every day between July 11, 2011 and July 13, 2011. The stock price saw one of its best stretches over the last year between May 19, 2011, and May 27, 2011, when shares rose for seven-straight days, rising 3% (+$1.83) over that span. Shares are up $5.95 (+11.1%) year to date.

(Source: Xignite Financials)

Get Actionable Investing Insights: Check Out Wall St. Cheat Sheet’s newest Feature Trades of the Month!